Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Changes in Stockholders' (Deficit)

v3.20.4
Consolidated Statements of Changes in Stockholders' (Deficit) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at the beginning of the period at Sep. 30, 2019 $ 172,612 $ 37,885,151 $ (38,865,060) $ (807,297)
Balance at the beginning of the period (in shares) at Sep. 30, 2019 172,612,233      
Net loss $ 0 0 (1,659,754) (1,659,754)
Issuance of common stock and warrants, net of financing costs $ 14,286 2,152,876 0 2,167,162
Issuance of common stock and warrants, net of financing costs (in shares) 14,285,714      
Stock based compensation expense $ 0 199,052 0 199,052
Balance at the ending of the period at Dec. 31, 2019 $ 186,898 40,237,079 (40,524,814) (100,837)
Balance at the ending of the period (in shares) at Dec. 31, 2019 186,897,947      
Balance at the beginning of the period at Sep. 30, 2020 $ 193,045 41,862,901 (43,556,437) $ (1,500,491)
Balance at the beginning of the period (in shares) at Sep. 30, 2020 193,044,766     193,044,766
Net loss $ 0 0 (1,154,104) $ (1,154,104)
Stock based compensation expense 0 85,611 0 85,611
Balance at the ending of the period at Dec. 31, 2020 $ 193,045 $ 41,948,512 $ (44,710,541) $ (2,568,984)
Balance at the ending of the period (in shares) at Dec. 31, 2020 193,044,766     193,094,766